Efficacy and toxicity of IFN‐α2b combined with cytarabine in chronic myelogenous leukaemia

Lindauer, Domkin, Döhner, Kolb… - British journal of …, 1999 - Wiley Online Library
Newly diagnosed chronic myelogenous leukaemia (CML) patients (n= 65) were treated with
interferon (IFN)‐α2b (5× 106 IU/d sc) combined with monthly courses of cytarabine (20 mg/d …

[引用][C] Efficacy and toxicity of IFN-α2b combined with cytarabine in chronic myelogenous leukaemia

M LINDAUER, D DOMKIN, T FISCHER… - British journal of …, 1999 - pascal-francis.inist.fr
Efficacy and toxicity of IFN-α2b combined with cytarabine in chronic myelogenous
leukaemia CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …

Efficacy and toxicity of IFN-alpha2b combined with cytarabine in chronic myelogenous leukaemia.

M Lindauer, D Domkin, H Döhner, HJ Kolb… - British Journal of …, 1999 - europepmc.org
Newly diagnosed chronic myelogenous leukaemia (CML) patients (n= 65) were treated with
interferon (IFN)-alpha2b (5 x 106 IU/d sc) combined with monthly courses of cytarabine (20 …

Efficacy and toxicity of IFN-alpha2b combined with cytarabine in chronic myelogenous leukaemia

M Lindauer, D Domkin, H Döhner… - British journal of …, 1999 - pubmed.ncbi.nlm.nih.gov
Newly diagnosed chronic myelogenous leukaemia (CML) patients (n= 65) were treated with
interferon (IFN)-alpha2b (5 x 106 IU/d sc) combined with monthly courses of cytarabine (20 …

[引用][C] Efficacy and toxicity of IFN-α2b combined with cytarabine in chronic myelogenous leukaemia

M LINDAUER, D DOMKIN, H DÖHNER… - British journal of …, 1999 - Blackwell